The Future of Stem Cell Manipulation

The clinical trial was published in New England Journal of Medicine. And so it's shown some promise that not only that these stem cells recolonize the bone marrow, but then the percentage of hemoglobin in the circulation now is, you know, 60% fetal hemoglobin. It still have to follow out the stage three to just ensure that it's no off target effects. But I think we'll find ways around...